v3.26.1
Financial instruments
12 Months Ended
Mar. 31, 2026
Disclosure of detailed information about financial instruments [abstract]  
Financial instruments

37.    Financial instruments

 

Financial instruments by category

 

The carrying value and fair value of financial instruments by each category as of March 31, 2026 were as follows:

 

Particulars

 

Note

 

Financial assets/ liabilities at amortized costs

 

Financial assets / liabilities at FVTPL

 

Financial assets / liabilities at FVTOCI

 

Total carrying value

 

Total fair value

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

8

 

4,098

 

-

 

-

 

4,098

 

4,098

Other bank balances

 

8

 

974

 

 

 

 

 

974

 

974

Trade receivables

 

16

 

12,648

 

-

 

-

 

12,648

 

12,648

Other financial assets

 

12 & 17

 

3,018

 

9

 

-

 

3,027

 

3,027

Investments

 

11

 

447

 

-

 

958

 

1,405

 

1,405

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Bank overdraft

 

8

 

-

 

-

 

-

 

-

 

-

Lease liabilities

 

7

 

3,902

 

-

 

-

 

3,902

 

3,902

Other financial liabilities

 

21 & 24

 

3,387

 

-

 

-

 

3,387

 

3,387

Borrowings from banks

 

20

 

25,094

 

-

 

-

 

25,094

 

25,094

Supplier finance arrangements

 

20

 

4,011

 

-

 

-

 

4,011

 

4,011

Borrowings from others

 

20

 

6,999

 

-

 

-

 

6,999

 

6,999

Trade payables

 

23

 

7,455

 

-

 

-

 

7,455

 

7,455

6% Compulsorily Convertible Debentures

 

21

 

4,000

 

-

 

-

 

4,000

 

4,000

8.95% Non - convertible Debentures

 

20

 

2,500

 

-

 

-

 

2,500

 

2,500

 

The carrying value and fair value of financial instruments by each category as of March 31, 2025, were as follows:

 

Particulars

 

Note

 

Financial assets/ liabilities at amortized costs

 

Financial assets / liabilities at FVTPL

 

Financial assets / liabilities at FVTOCI

 

Total carrying value

 

Total fair value

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

8

 

4,997

 

-

 

-

 

4,997

 

4,997

Other bank balances

 

8

 

1,761

 

 

 

 

 

1,761

 

1,761

Trade receivables

 

16

 

10,916

 

-

 

-

 

10,916

 

10,916

Other financial assets

 

12 & 17

 

2,693

 

19

 

-

 

2,712

 

2,712

Investments

 

11

 

404

 

-

 

825

 

1,229

 

1,229

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Bank overdraft

 

8

 

326

 

-

 

-

 

326

 

326

Lease liabilities

 

7

 

3,810

 

-

 

-

 

3,810

 

3,810

Other financial liabilities

 

21 & 24

 

2,220

 

-

 

-

 

2,220

 

2,220

Borrowings from banks

 

20

 

20,925

 

-

 

-

 

20,925

 

20,925

Supplier finance arrangements

 

20

 

4,106

 

-

 

-

 

4,106

 

4,106

Borrowings from others

 

20

 

5,689

 

-

 

-

 

5,689

 

5,689

Trade and other payables

 

23

 

8,052

 

-

 

-

 

8,052

 

8,052

6% Compulsorily Convertible Debentures

 

20

 

6,260

 

-

 

-

 

6,260

 

6,260

8.95% Non - convertible Debentures

 

20

 

2,500

 

-

 

-

 

2,500

 

2,500

 

Details of financial assets hypothecated as collateral

 

The carrying amount of financial assets as at March 31, 2026 and 2025 that the Group has provided as collateral for obtaining borrowings and other facilities from its bankers are as follows:

 

 

 

As of

 

 

March 31, 2026

 

March 31, 2025

Cash and cash equivalents

 

2,993

 

2,110

Trade receivables

 

7,637

 

3,377

 

 

10,630

 

5,487

 

Derivative financial instruments

 

 

(a)

Forwards and options

 

Foreign exchange forward contracts and options are purchased to mitigate the risk of changes in foreign exchange rates associated with certain payables, receivables and forecasted transactions denominated in certain foreign currencies. These derivative contracts do not qualify for hedge accounting under IFRS 9 and are initially recognized at fair value on the date the contract is entered into and subsequently re-measured at their fair value. Gains or losses arising from changes in the fair value of the derivative contracts are recognized immediately in profit or loss. The counterparties for these contracts are generally banks or financial institutions.

 

The following table gives details in respect of the notional amount of outstanding foreign exchange contracts as at March 31, 2026 and 2025.

 

 

 

As of

 

 

March 31, 2026

 

March 31, 2025

Forward contracts

 

 

 

 

In U.S. Dollars (Sell)

 

2

 

-

In U.S. Dollars (Buy)

 

-

 

-

(Gain) / loss on mark to market in respect of forward contracts outstanding

 

2

 

-

 

The Company recognized a net loss on the forward contracts of ₹ 2 million (March 31, 2025: ₹ Nil – Net loss) for the year ended March 31, 2026.

 

The forward exchange contracts and option contracts mature between one and twelve months. The table below summarizes the notional amounts of derivative financial instruments into relevant maturity groupings based on the remaining period as at the end of the year:

 

 

 

As of

 

 

March 31, 2026

 

March 31, 2025

Sell:

 

(US $)

 

(US $)

Not later than one month

 

-

 

-

Later than one month and not later than three months

 

2

 

-

Later than three months and not later than six months

 

-

 

-

Later than six months and not later than one year

 

-

 

-

 

 

(b)

Cross Currency Swap:

 

The Group has entered into Cross Currency Swaps in order to hedge the cash flows arising out of the Principal and Interest payments of the underlying External Commercial Borrowing denominated in USD. The period of the swap contracts is co-terminus with the period of the underlying ECB. As per the terms of the arrangement, the Company shall pay INR fixed and receive fixed USD principal and interest cash flows during the term of the contract. The swap arrangement is marked to market at the end of every period and losses are recognized in the Statement of Income.

 

The swap contracts outstanding balances as on March 31, 2026 and March 31, 2025 is as follows.

 

Particulars

 

Value of the outstanding INR term loan

 

Value of the outstanding USD principal

 

Mark to Market losses/ (gain)

Tranche 1

 

15

 

USD 0.2

 

3

Tranche 2

 

22

 

USD 0.3

 

5

Total

 

37

 

 USD 0.5

 

8

 

Particulars

 

Value of the outstanding INR term loan

 

Value of the outstanding USD principal

 

Mark to Market losses/ (gain)

Tranche 1

 

44

 

USD 0.6

 

3

Tranche 2

 

66

 

USD 0.9

 

5

Total

 

110

 

 USD 1.5

 

8

 

The maturity of these contracts extends for five years and six months. The table below summarizes the cash flows (principal) of these derivative financial instruments into relevant maturity groupings based on the remaining period as at the end of the year:

 

 

 

As at

 

As at

 

 

March 31, 2026

 

March 31, 2025

Particulars

 

Payable (USD)

 

Receivable (INR)

 

Payable (USD)

 

Receivable (INR)

Less than 1 year

 

0.50

 

37

 

1.00

 

73

One to two years

 

-

 

-

 

0.50

 

37

Two to three years

 

-

 

-

 

-

 

-

Three to four years

 

-

 

-

 

-

 

-

Four to five years

 

-

 

-

 

-

 

-

More than five years

 

-

 

-

 

-

 

-

Total cash flows

 

0.50

 

37

 

1.50

 

110

 

The Group recognized a net loss on the cross-currency swaps of 8 [Previous year : ₹ 8] for the year ended March 31, 2026.

 

 

(c)

Interest Rate Swap:

 

The Group has entered into Interest Rate Swaps in order to hedge the cash flows arising out of the Interest payments of the underlying ECB. The period of the swap contract is co-terminus with the period of the underlying ECB. As per the terms of the arrangement, the Company shall pay fixed rate of interest (8.9%) and receive variable rate of interest equal to SOFR + 2.5% on notional amount. The swap arrangement is marked to market at the end of every period and losses are recognized in the Statement of income.

 

The maturity of these contracts extends for five years and six months. The table below summarizes the cash flows (interest) of these derivative financial instruments into relevant maturity groupings based on the remaining period at the end of the year:

 

 

 

As of

 

 

March 31, 2026

 

March 31, 2025

 

 

Receivable

 

Payable

 

Receivable

 

Payable

 

 

(US $)

 

(US $)

 

(US $)

 

(US $)

 

 

 

 

 

 

 

 

 

Less than 1 year*

 

0

 

1

 

0

 

7

One to two years*

 

-

 

-

 

0

 

1

Two to three years

 

-

 

-

 

-

 

-

Three to four years

 

-

 

-

 

-

 

-

Four to five years

 

-

 

-

 

-

 

-

More than five years

 

-

 

-

 

-

 

-

Total cash flows

 

0

 

1

 

0

 

8

  

 

*

Amount below rounding off norm adopted by the Group

 

Total notional amount outstanding as of March 31, 2026 is US$ 0.50 (March 31, 2025: US$ 1.50).

 

Net Loss on account of interest rate swaps amount to ₹ Nil for the year ended March 31, 2026 (March 31, 2025: ₹ Nil – Net loss).

 

Fair value measurements:

 

The details of assets and liabilities that are measured on fair value on recurring basis are given below:

 

 

 

Fair value as of March 31, 2026

 

Fair value as of March 31, 2025

 

 

Level 1

 

Level 2

 

Level 3

 

Level 1

 

Level 2

 

Level 3

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Derivative financial assets gain on outstanding forward/options contracts

 

-

 

-

 

-

 

-

 

-

 

-

Derivative financial assets - gain on outstanding cross currency swaps

 

-

 

-

 

11

 

-

 

-

 

19

Derivative financial assets - gain on outstanding interest rate swaps

 

-

 

-

 

-

 

-

 

-

 

-

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Derivative financial liabilities loss on outstanding forward/options contracts

 

-

 

-

 

2

 

-

 

-

 

-

Derivative financial liabilities - loss on outstanding cross currency swaps

 

-

 

-

 

-

 

-

 

-

 

-

Derivative financial liabilities - loss on outstanding interest rate swaps

 

-

 

-

 

-

 

-

 

-

 

-

 

 

Level 1 unadjusted quoted prices in active markets for identical assets and liabilities.

 

 

Level 2 Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices).

 

 

Level 3 unobservable inputs for the asset or liability.

 

Interest income/ (expenses), gains/ (losses) recognized on financial assets and liabilities

 

Recognized in profit or loss

 

 

 

Year ended

 

 

March 31, 2026

 

March 31, 2025

 

March 31, 2024

Financial assets at amortized cost

 

 

 

 

 

 

Interest income on bank deposits

 

150

 

346

 

231

Interest income from other financial assets

 

24

 

44

 

30

Impairment loss of trade receivables

 

(164)

 

(195)

 

(265)

 

 

 

 

 

 

 

Financial assets at fair value through profit or loss

 

 

 

 

 

 

Net change in fair value of derivative financial instruments gain/(loss)

 

9

 

8

 

8

 

 

 

 

 

 

 

Financial liabilities at amortized cost

 

 

 

 

 

 

Interest expenses on lease obligations

 

(336)

 

(299)

 

(250)

Interest expenses on borrowings from banks, others and overdrafts

 

(3,386)

 

(2,282)

 

(1,738)